Janoshazi A, Solomon A K
Biophysical Laboratory, Harvard Medical School, Boston, Massachusetts 02115.
J Membr Biol. 1989 Nov;112(1):25-37. doi: 10.1007/BF01871161.
The time course of binding of the fluorescent stilbene anion exchange inhibitor. DBDS (4.4'-dibenzamido-2.2'-stilbene disulfonate), to band 3 can be measured by the stopped-flow method. We have previously used the reaction time constant. tau DBDS, to obtain the kinetic constants for binding and, thus, to report on the conformational state of the band 3 binding site. To validate the method, we have now shown that the ID50 (0.3 +/- 0.1 microM) for H2-DIDS (4.4'-diisothiocyano-2.2'-dihydrostilbene disulfonate) inhibition of tau DBDS is virtually the same as the ID50 (0.47 +/- 0.04 microM) for H2-DIDS inhibition of red cell Cl- flux, thus relating tau DBDS directly to band 3 anion exchange. The specific glucose transport inhibitor, cytochalasin B, causes significant changes in tau DBDS, which can be reversed with intracellular, but not extracellular, D-glucose, ID50 for cytochalasin B modulation of tau DBDS is 0.1 +/- 0.2 microM in good agreement with KD = 0.06 +/- 0.005 microM for cytochalasin B binding to the glucose transport protein. These experiments suggest that the glucose transport protein is either adjacent to band 3, or linked to it through a mechanism, which can transmit conformational information. Ouabain (0.1 microM), the specific inhibitor of red cell Na+,K+-ATPase, increases red cell Cl- exchange flux in red cells by a factor of about two. This interaction indicates that the Na+,K+-ATPase, like the glucose transport protein, is either in contact with, or closely linked to, band 3. These results would be consistent with a transport protein complex, centered on band 3, and responsible for the entire transport process, not only the provision of metabolic energy, but also the actual carriage of the cations and anions themselves.
荧光芪阴离子交换抑制剂DBDS(4,4'-二苯甲酰胺基-2,2'-芪二磺酸盐)与带3蛋白结合的时间进程可通过停流法进行测定。我们之前使用反应时间常数τDBDS来获取结合的动力学常数,从而报告带3蛋白结合位点的构象状态。为验证该方法,我们现已表明,H2-DIDS(4,4'-二异硫氰酸基-2,2'-二氢芪二磺酸盐)对τDBDS抑制的ID50(0.3±0.1微摩尔)与H2-DIDS对红细胞Cl-通量抑制的ID50(0.47±0.04微摩尔)几乎相同,从而将τDBDS与带3蛋白阴离子交换直接关联起来。特异性葡萄糖转运抑制剂细胞松弛素B会使τDBDS发生显著变化,细胞内而非细胞外的D-葡萄糖可使其逆转,细胞松弛素B对τDBDS调节的ID50为0.1±0.2微摩尔,与细胞松弛素B结合葡萄糖转运蛋白的KD = 0.06±0.005微摩尔高度一致。这些实验表明,葡萄糖转运蛋白要么与带3蛋白相邻,要么通过一种能够传递构象信息的机制与之相连。哇巴因(0.1微摩尔),红细胞Na +,K + -ATP酶的特异性抑制剂,可使红细胞中的红细胞Cl-交换通量增加约两倍。这种相互作用表明,Na +,K + -ATP酶与葡萄糖转运蛋白一样,要么与带3蛋白接触,要么与之紧密相连。这些结果与以带3蛋白为中心的转运蛋白复合物相符,该复合物负责整个转运过程,不仅提供代谢能量,还负责阳离子和阴离子本身的实际运输。